Palladium and copper-catalyzed ligand-free coupling of phenylhydrazines in water

Parul Chauhan a, Makthala Ravia, Shikha Singha, Kanumuri S. R. Rajuc, Vikas Bajpaib, Brijesh Kumarb, Wahajuddinc and Prem. P. Yadav*a
aDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow-226031, India. E-mail: pp_yadav@cdri.res.in; ppy_cdri@yahoo.co.in; Fax: +91-522-2623405/2623938; Tel: +91-522-2612411-18 ext. 4761/4762
bSophisticated Analytical Instrument Facility, CSIR-Central Drug Research Institute, Lucknow-226031, India
cDivision of Pharmacokinetics and Metabolism, CSIR-Central Drug Research Institute, Lucknow-226031, India

Received 16th May 2014 , Accepted 4th September 2014

First published on 5th September 2014


Abstract

An efficient protocol has been developed for the synthesis of biaryls via Pd/Cu catalyzed coupling of phenylhydrazines in water. Homo and cross couplings were successfully achieved in a ligand-free catalytic system, at room temperature with water as sole reaction medium.


The palladium catalyzed carbon–carbon bond forming reactions are the most important synthetic routes for the generation of biaryls towards construction of natural products and medicinally important molecules. Over the past few decades organometallic methods have impacted tremendously on selective biaryl couplings. Use of water as solvent in these reactions is more recent and limited because of sensitivity, poor solubility of substrate/ligand and use of co-solvent or phase transfer agents.1 Various biaryl couplings of suitably functionalized arenes such as aryl halides,2 aryl triflates,3 aryl diazonium salts,4 arylboronic acids,5 aryl acids,6 aryl magnesium salt,7 aryl tosyl/mesyl hydrazines,8 etc. are well known in the literature (Scheme 1). All these processes have provided alternative methodologies for biaryl couplings with associated limitations. In the recent past, Cu/Ag has gained special attention as a co-catalyst to facilitate reactions by crucial transmetallation to deliver an aryl-Pd(II) complex in Pd(0)/Pd(II) catalytic cycle. Among, most notable processes are decarboxylative cross coupling processes in which a Cu(I)/Ag(I) co-catalyst catalyzes the expulsion of CO2 followed by transmetallation and reductive elimination to deliver biaryls.9 Also a bimetallic Pd/Cu catalyzed desulfitative C–C coupling of sodium salt of aryl sulfinates was reported in water.10 Inspired by the bimetallic processes11 and vast literature on biaryl synthesis from functionalized hydrazines12 and hydrazones,13 we designed a Pd/Cu catalytic system to achieve an easy and efficient homo and cross coupling of phenylhydrazines. We hypothesized that water soluble phenylhydrazine hydrochloride salts can be easily converted into diazene by a Cu(II) oxidant and the resulted diazene may be subjected to Pd catalyzed C–C bond formation to afford biaryls. To investigate our hypothesis we chose 4-fluorophenyl hydrazine as a model substrate.
image file: c4ra04621h-s1.tif
Scheme 1 Strategies for the synthesis of biaryls.

We started the reaction of 1a in the presence of palladium acetate (5 mol%) and copper acetate (10 mol%) in water for 20 min at r.t. To our delight, the reaction proceeded smoothly and provided biaryl 2a in 80% yield (Table 1, entry 1). To the best of our knowledge, this is the first report on Pd catalyzed synthesis of biaryls from phenylhydrazines using Cu as an oxidant in water.

Table 1 Optimization of catalyst for coupling reactiona

image file: c4ra04621h-u1.tif

Entry Pd source X Y Solvent Time Yieldb (%)
a Reaction condition: 1a (0.62 mmol), catalyst (X mol%), Cu(OAc)2 (Y mol%), solvent (10 mL) at rt.b Isolated yields.c Equivalents.
1 Pd(OAc)2 5 10 H2O 20 min 80
2 Pd(TFA)2 2.5 10 H2O 15 min 90
3 Pd(TFA)2 5 10 H2O 15 min 90
4 PdCl2 5 10 H2O 1 h 75
5 Pd(PPh3)2Cl2 5 10 H2O 2 h 65
6 Pd(PPh3)4 5 10 H2O 3.5 h 41
7 Pd(TFA)2 2.5 5 H2O 2 h 78
8 Pd(TFA)2 2.5 20 H2O 15 min 90
9 Pd(TFA)2 2.5 10 DMF 15 min 90
10 Pd(TFA)2 2.5 10 EtOH 20 min 80
11 Pd(TFA)2 2.5 10 THF 20 min 80
12 Pd(TFA)2 2.5 10 MeOH 20 min 75
13 Pd(TFA)2 2.5 10 DMSO 20 min 85
14 Pd(TFA)2 2.5 10 Toluene 20 min 65
15 PdCl2 2.5 10 DMF 1 h 79
16 Pd(PPh3)2Cl2 2.5 10 DMF 2 h 67
17 Pd(PPh3)4 2.5 10 DMF 3.5 h 42
18 Pd(OAc)2 2.5 10 DMF 2 h 80
19 Pd(TFA)2 1c H2O 15 min 0
20 1c H2O 15 min 0


Encouraged by these results, we next evaluated various Pd(II) sources (Table 1, entries 1–6) and found that Pd(TFA)2 (2.5 mol%) is the best Pd source, affording 90% yield of 2a (Table 1, entry 2). Increasing the catalytic loading of palladium from 2.5 mol% to 5 mol% there was no improvement in yield (Table 1, entry 2 versus entry 3). Further a set of reactions were performed to investigate the influence of catalytic amount of copper acetate and found that 10 mol% copper acetate provided best yield (Table 1, entry 2), 5 mol% of copper acetate led to reduction of yield to 78% (Table 1, entry 7) and no further improvement was observed while increasing catalytic loading to 20 mol% (Table 1, entry 8). Other copper sources such as CuCl2 and CuBr2 provided moderate yields (Table 2, entries 1–2), whereas Cu(I) sources such as CuI and Cu2O resulted in abrupt reduction in yields (Table 2, entries 3–4). Non-copper oxidants such as Ag2CO3, TBHP and Iodine were also screened (Table 2, entries 5–7) and none of them were more efficient than the copper acetate for this conversion. Other organic solvents (Table 1, entries 9–14) were also screened and found to give moderate to high yield of 2a where reaction in DMF provided almost comparable yield as compared to water (Table 1, entries 9 and 5–18). After having promising results in hand for the model system, the scope of substituted phenylhydrazines was investigated (Table 3). Optimized protocol was applied to a range of mono (Table 3, entries 1–6 and 8) and disubstituted (Table 3, entries 7 and 9) phenylhydrazines to afford good to excellent yield of corresponding biaryls. Reactions of phenylhydrazines having electron withdrawing groups such as fluoro, chloro, bromo, cyano, nitro and dichloro (Table 3, entries 1a–1c and 1e–1g) and electron donating groups such as methoxy and dimethyl (Table 3, entries 8 and 9) proceeded with similar efficiency and afforded 2a–2i in 68–90% yields (Table 3, entries 1–9).

Table 2 Effect of co-catalyst (oxidant)a

image file: c4ra04621h-u2.tif

Entry Co-catalyst Time Yieldb
a Reaction condition: 1a (0.62 mmol), Pd(TFA)2 (2.5 mol%), co-catalyst (10 mol%), water (10 mL) at rt.b Isolated yields.c TBHP (1 equivalent).d TBHP (1 equivalent) + CuI (10 mol%).
1 CuCl2 30 min 68
2 CuBr2 30 min 85
3 CuI 1 h 35
4 Cu2O 2 h None
5 Ag2CO3 30 min 60
6 TBHPc 1 h 55
7 Iodine 30 min 51
8 TBHP + CuId 20 min 85


Table 3 Homocoupling of substituted phenylhydrazinesa

image file: c4ra04621h-u3.tif

Entry R Product Time Yieldb (%)
a Reaction condition: 1a (0.62 mmol), Pd(TFA)2 (2.5 mol%), oxidant (10 mol%), water (10 mL) at rt.b Isolated yields.
1 4-F image file: c4ra04621h-u4.tif 15 min 90
2 4-Br image file: c4ra04621h-u5.tif 20 min 85
3 4-Cl image file: c4ra04621h-u6.tif 15 min 90
4 H image file: c4ra04621h-u7.tif 20 min 82
5 4-CN image file: c4ra04621h-u8.tif 1 h 69
6 4-NO2 image file: c4ra04621h-u9.tif 30 min 81
7 3,4-Di-Cl image file: c4ra04621h-u10.tif 25 min 79
8 4-OMe image file: c4ra04621h-u11.tif 2 h 68
9 3,4-Di-Me image file: c4ra04621h-u12.tif 1 h 80


Notably, halogen groups were compatible with this reaction (2a–2c). Most of the C–C coupling strategies use aryl halides as aryl source, whereas in our process halides are retained in the coupled product. Further cyano and nitro groups are also compatible with present methodology. These functional groups are important post coupling diversification points in medicinal chemistry.14

The present method also afforded unique 4,4′-biquinoline efficiently and may prove to be a key process for synthesis of biologically active biheterocycles (Scheme 2).15


image file: c4ra04621h-s2.tif
Scheme 2 Synthesis of 4,4′-biquinoline.

We tested our methodology for cross coupling reactions of chloro, bromo, fluoro and cyano substituted phenylhydrazines with methoxy and cyano substituted phenylhydrazine under optimized reaction condition (Table 1, entry 2). Cross coupling proceeded smoothly and afforded desired unsymmetrical biaryls (3) in 41–76% yields (Table 4, entries 1–6).

Table 4 Cross-coupling of substituted phenylhydrazinesa

image file: c4ra04621h-u13.tif

Entry R R1 Cross coupling product (3) Time Yieldb(%) (3, 2, 2′)
a Reaction condition: 1 (0.57 mmol), 1′ (0.68 mmol), Pd(TFA)2, (2.5 mol%), Cu(OAc)2 (10 mol%), water (10 mL) at rt.b HPLC yields.
1 Cl OMe image file: c4ra04621h-u14.tif 2 h 76, 2, 21
2 Br OMe image file: c4ra04621h-u15.tif 2.5 h 75, 6, 19
3 F OMe image file: c4ra04621h-u16.tif 2 h 71, 13, 15
4 CN OMe image file: c4ra04621h-u17.tif 3.5 h 41, 55, 3
5 Cl CN image file: c4ra04621h-u18.tif 2.5 h 59, 11, 30
6 Br CN image file: c4ra04621h-u19.tif 2.5 h 64, 25, 10


The methodology was further extended for synthesis of anticancer pharmacophore 2-arylbenzothiazole16 (Scheme 3) and Suzuki coupling of aryl boronic acids with phenylhydrazines (Scheme 4).


image file: c4ra04621h-s3.tif
Scheme 3 Synthesis of 2-arylbenzothiazole.

image file: c4ra04621h-s4.tif
Scheme 4 Pd/Cu catalyzed Suzuki coupling of arylhydrazines hydrochloride in water.

Recently, Zhao et al., reported Pd-catalyzed Suzuki coupling of phenylhydrazines with arylboronic acid using phosphine ligands, acids and NMP as solvent at 90 °C.17 Peng et al., also reported Pd-catalyzed Suzuki coupling of phenylhydrazines with arylboronic acid while using TsCl for activation of hydrazine, SDS as PTC in water at 60 °C.18 We herein executed Suzuki cross-coupling of 4-methoxyphenylboronic acid with 4-chlorophenylhydrazine (Scheme 4) under our optimized conditions in water at room temperature without using any hydrazine activation agents like TsCl, ligand and PTC. Further optimization of yield is under progress.

We next conducted some experiments to investigate the role of metals in this reaction. When phenylhydrazine 1a was reacted under optimized conditions with Pd(TFA)2 in absence of Cu(II), no product was observed (Table 1, entry 19). Similarly reaction without Pd(TFA)2 but with Cu(OAc)2 under optimized condition did not afford any biaryl product indicating that both of these metals are essential for coupling (Table 1, entry 20). Also TEMPO displayed a negligible effect on the reaction of 1a in the presence of Pd/Cu to afford 2a, ruling out a radical pathway.

Although a detailed study is required to fully understand the exact mechanism of homo and cross coupling of phenylhydrazines and role of Cu in catalytic cycle, a tentative pathway can be proposed on the basis of our observations and previous reports on phenylhydrazine couplings8,13a (Fig. 1). Phenylhydrazine A undergoes oxidation in the presence of Cu(II) to form diazene intermediate B or complex C, which subsequently undergoes transmetalation with Pd(II) followed by expulsion of N2 to afford intermediate E. A second transmetalation of intermediate E with C or B to produce a bis-aryl palladium(II) species F, which subsequently undergoes reductive elimination to afford the desired homo and cross-coupled product G and Pd(0). Finally Pd(0) undergo oxidation to Pd(II) completing the catalytic cycle.


image file: c4ra04621h-f1.tif
Fig. 1 Proposed mechanism.

Conclusions

In conclusion, biphenyls were synthesized by an efficient Pd/Cu catalytic system from unprotected phenylhydrazines in water. The reaction displayed a better functional group tolerance towards electron donating as well as electron withdrawing groups. Interestingly unsymmetrical biaryl products have moderate selectivity over symmetrical ones in cross coupling reactions. Air and water tolerance, ligand-free catalysis along with high yields at room temperature are key features of this methodology. Further scope of this reaction is in progress for construction of biologically important compounds in our laboratory.

Acknowledgements

P.C., M.R. and S.S. are thankful to the Council of Scientific and Industrial Research (CSIR), New Delhi, for Fellowship, Mr A. K. Srivastava and Mr R. K. Purshottam for providing technical support, SAIF-CDRI Lucknow for providing spectral and analytical data. This work was supported by CSIR network project “HOPE” (BSC0114). This is CDRI communication no. 8785.

Notes and references

  1. (a) N. Liu, C. Liu and Z. Jin, Green Chem., 2012, 14, 592 RSC; (b) C. Zhou, J. Wang, L. Li, R. Wang and M. Hong, Green Chem., 2011, 13, 2100 RSC; (c) S. S. Soomro, C. Rohlich and K. Kohler, Adv. Synth. Catal., 2011, 353, 767 CrossRef CAS PubMed; (d) M. J. Jin and D. H. Lee, Angew. Chem., Int. Ed., 2010, 49, 1119 CrossRef CAS PubMed; (e) B. Basu, K. Biswas, S. Kundu and S. Ghosh, Green Chem., 2010, 12, 1734 RSC.
  2. (a) W. M. Seganish, M. E. Mowery, S. Riggleman and P. Deshong, Tetrahedron, 2005, 61, 2117 CrossRef CAS PubMed; (b) L. Marciasini, N. Richy, M. Vaultier and M. Pucheault, Chem. Commun., 2012, 48, 1553 RSC; (c) G. Li, C. Liu, Y. Lei and R. Jin, Chem. Commun., 2012, 48, 12005 RSC; (d) S. B. Park and H. Alper, Tetrahedron Lett., 2004, 45, 5515 CrossRef CAS PubMed; (e) L. Wang, Y. Zhang, L. Liu and Y. Wang, J. Org. Chem., 2006, 71, 1284 CrossRef CAS PubMed; (f) D. Toummini, F. Ouazzani and M. Taillefer, Org. Lett., 2013, 15, 4690 CrossRef CAS PubMed; (g) L. Wang and W. Lu, Org. Lett., 2009, 11, 1079 CrossRef CAS PubMed.
  3. A. Jutand and A. Mosleh, J. Org. Chem., 1997, 62, 261 CrossRef CAS PubMed.
  4. (a) K. Cheng, C. Wang, Y. Ding, Q. Song, C. Qi and X.-M. Zhang, J. Org. Chem., 2011, 76, 9261 CrossRef CAS PubMed; (b) K. Cheng, B. Zhao, S. Hu, X.-M. Zhang and C. Qi, Tetrahedron Lett., 2013, 54, 6211 CrossRef CAS PubMed; (c) M. K. Robinson, V. S. Kochurina and J. M. Hanna, Tetrahedron Lett., 2007, 48, 7687 CrossRef CAS PubMed; (d) X. Zhu, F. Li and W. Su, Tetrahedron Lett., 2013, 54, 1285 CrossRef CAS PubMed; (e) A. Zarei, L. Khazdooz, A. R. Hajipour, F. Rafiee, G. Azizi and F. Abrishami, Tetrahedron Lett., 2012, 53, 406 CrossRef CAS PubMed; (f) J. Salabert, R. M. Sebastian, A. Vallribera, J. F. Civicos and C. Najera, Tetrahedron, 2013, 69, 2655 CrossRef CAS PubMed.
  5. (a) T. Matsuda, T. Asai, S. Shiose and K. Kato, Tetrahedron Lett., 2011, 52, 4779 CrossRef CAS PubMed; (b) J. R. Falck, S. Mohapatra, M. Bondlela and S. K. Venkataraman, Tetrahedron Lett., 2002, 43, 8149 CrossRef CAS; (c) K. Mitsudo, T. Shiraga, D. Kagen, D. Shi, J. Y. Becker and H. Tanaka, Tetrahedron, 2009, 65, 8384 CrossRef CAS PubMed; (d) A. S. Demir, H. Findik, N. Saygili and N. T. Subasi, Tetrahedron, 2010, 66, 1308 CrossRef CAS PubMed.
  6. (a) P. Hu, Y. Shang and W. Su, Angew. Chem., Int. Ed., 2012, 51, 5945 CrossRef CAS PubMed; (b) K. Xie, S. Wang, Z. Yang, J. Liu, A. Wang, X. Li, Z. Tan, C.-C. Guo and W. Deng, Eur. J. Org. Chem., 2011, 5787 CrossRef CAS PubMed.
  7. (a) A. Krasovskiy, A. Tishkov, V. D. Amo, H. Mayr and P. Knochel, Angew. Chem., Int. Ed., 2006, 45, 5010 CrossRef CAS PubMed; (b) M. S. Maji, T. Pfeifer and A. Studer, Angew. Chem., Int. Ed., 2008, 47, 9547 CrossRef CAS PubMed; (c) G. Kiefer, L. Jeanbourquin and K. Severin, Angew. Chem., Int. Ed., 2013, 52, 1 CrossRef PubMed; (d) T. Nagano and T. Hayashi, Org. Lett., 2005, 7, 491 CrossRef CAS PubMed; (e) W. Liu and A. Lei, Tetrahedron Lett., 2008, 49, 610 CrossRef CAS PubMed.
  8. (a) J.-B. Liu, L. Nie, H. Yan, L.-H. Jiang, J. Weng and G. Lu, Org. Biomol. Chem., 2013, 11, 8014 RSC; (b) H.-P. Zhou, J.-B. Liu, J.-J. Yuan and Y.-Y. Peng, RSC Adv., 2014, 4, 25576 RSC.
  9. J. Cornella, H. Lahlali and I. Larrosa, Chem. Commun., 2010, 46, 8276 RSC.
  10. B. Rao, W. Zhang, L. Hu and M. Luo, Green Chem., 2012, 14, 3436 RSC.
  11. M. H. Perez-Temprano, J. A. Casares and P. Espinet, Chem.–Eur. J., 2012, 18, 1864 CrossRef CAS PubMed.
  12. (a) A. S. Demir, O. Reis and E. Ozgul-Karaaslan, J. Chem. Soc., Perkin Trans. 1, 2001, 3042 RSC; (b) A. S. Demir, O. Reis and M. Emrullahoglu, Tetrahedron, 2002, 58, 8055 CrossRef CAS; (c) M.-K. Zhu, J.-F. Zhao and T.-P. Loh, Org. Lett., 2011, 13, 6308 CrossRef CAS PubMed; (d) Y. Bai, L. M. H. Kim, H. Liao and X.-W. Liu, J. Org. Chem., 2013, 78, 8821 CrossRef CAS PubMed; (e) P. Patil, A. Nimonkar and K. G. Akamanchi, J. Org. Chem., 2014, 79, 2331 CrossRef CAS PubMed; (f) J. Hofmann, H. Jasch and M. K. Heinrich, J. Org. Chem., 2014, 79, 2314 CrossRef CAS PubMed.
  13. (a) J.-B. Liu, H. Yan, H.-X. Chen, Y. Luo, J. Weng and G. Lu, Chem. Commun., 2013, 49, 5268 RSC; (b) J. Barluenga, L. Florentino, F. Aznar and C. Valdes, Org. Lett., 2011, 13, 510 CrossRef CAS PubMed; (c) Q. Xiao, Y. Zhang and J. Wang, Acc. Chem. Res., 2013, 46, 236 CrossRef CAS PubMed.
  14. (a) S. Santra, P. K. Hota, R. Bhattacharya, P. Bera, P. Ghosh and S. K. Mandal, ACS Catal., 2013, 3, 2776 CrossRef CAS; (b) G. Bringmann, T. Gulder, T. A. M. Gulder and M. Breuning, Chem. Rev., 2011, 111, 563 CrossRef CAS PubMed.
  15. J. M. Sheridan, J. R. Heal, W. D. O. Hamilton and I. Pike, WO Patent, 080729 A2, 2012.
  16. (a) S. Aiello, G. Wells, E. L. Stone, H. Kadri, R. Bazzi, D. R. Bell, M. F. G. Stevens, C. S. Matthews, T. D. Bradshaw and A. D. Westwell, J. Med. Chem., 2008, 51, 5135 CrossRef CAS PubMed; (b) C. G. Mortimer, G. Wells, J.-P. Crochard, E. L. Stone, T. D. Bradshaw, M. F. G. Stevens and A. D. Westwell, J. Med. Chem., 2006, 49, 179 CrossRef CAS PubMed.
  17. Z. Peng, G. Hu, H. Qiao, P. Xu, Y. Gao and Y. Zhao, J. Org. Chem., 2014, 79, 2733 CrossRef CAS PubMed.
  18. J.-B. Liu, H.-P. Zhou and Y.-Y. Peng, Tetrahedron Lett., 2014, 55, 2872 CrossRef CAS PubMed.

Footnotes

Electronic supplementary information (ESI) available: Experimental procedures, data and NMR spectra of all the final compounds. See DOI: 10.1039/c4ra04621h
P.C and M.R. contributed equally to this work.

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.